Erratum: Modulation of neutrophil NETosis: Interplay between infectious agents and underlying host physiology (Seminars in Immunopathology DOI: 10.1007/s00281-013-0380-x);Modulation of neutrophil NETosis: Interplay between infectious agents and underlying host physiology

Seminars in Immunopathology

Volumn 35, Issue 4, 2013, Pages 439-453

  Hahn, Sinuhe ^a,c   Giaglis, Stavros ^a,b   Chowdury, Chanchal Sur ^a   Hösli, Irene ^a   Hasler, Paul ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

Author keywords

Infection; Lung; Modulation; Neutrophil extracellular traps (NETs); Pregnancy

Indexed keywords

ANTINUCLEAR ANTIBODY; BACTERIAL PROTEIN; BLOOD CLOTTING FACTOR 12; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHEPSIN G; CELL DNA; DEOXYRIBONUCLEASE; FUNGAL PROTEIN; HYDROPHOBIN; INTERLEUKIN 10; LEUKOCYTE ELASTASE; PYRIMETHAMINE PLUS SULFADOXINE; RODA PROTEIN; SDA1 PROTEIN; SIALIC ACID; SURFACTANT PROTEIN D; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANTIFUNGAL ACTIVITY; BACTERIAL CLEARANCE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CELL INTERACTION; CELL MATURATION; CONIDIUM; CYTOKINE PRODUCTION; ENDOCYTOSIS; ENZYME RELEASE; FELINE LEUKEMIA VIRUS; FUNGAL VIRULENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE EVASION; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; IMMUNOTHROMBOSIS; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; LEUKOCYTE FUNCTION; MACROPHAGE; MALARIA FALCIPARUM; MICROENVIRONMENT; MOLECULAR MIMICRY; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; OPSONIZATION; PATHOGENICITY; PLASMODIUM VIVAX MALARIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE ADHESION; THROMBOSIS; VIRUS CELL INTERACTION;

EID: 84879687648     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-013-0385-5     Document Type: Erratum

References (123)

1. Borregaard N (2010) Neutrophils, from marrow to microbes. Immunity 33:657-670
2. Mantovani A et al (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11:519-531
3. Brinkmann V et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532-1535
4. Urban CF et al (2006) Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol 8:668-676
5. Urban CF et al (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defence against Candida albicans. PLoS pathogens 5:e1000639
6. Bianchi M et al (2009) Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114:2619-2622
7. Bruns S et al (2010) Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS pathogens 6:e1000873
8. Medina E (2009) Neutrophil extracellular traps: a strategic tactic to defeat pathogens with potential consequences for the host. Journal of innate immunity 1:176-180
9. Ermert D et al (2009) Fungal and bacterial killing by neutrophils. Methods in molecular biology 470:293-312
10. Buchanan JT et al (2006) DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Current biology: CB 16:396-400
11. Beiter K et al (2006) An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Current biology: CB 16:401-407
12. Berends ET et al (2010) Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. Journal of innate immunity 2:576-586
13. Peterson EJ et al (2013) Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay. J Biomol Screen 18:247-257
14. Khatua B et al (2012) Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9. J Leukoc Biol 91:641-655
15. Varki A, Gagneux P (2012) Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253:16-36
16. Carlin AF et al (2009) Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113:3333-3336
17. Tamassia N et al (2013) Cutting edge: an inactive chromatin configuration at the IL-10 locus in human neutrophils. J Immunol 190:1921-1925
18. Huynh KK et al (2011) A delicate dance: host response to mycobacteria. Curr Opin Immunol 23:464-472
19. Torrado E et al (2011) Cellular response to mycobacteria: balancing protection and pathology. Trends in immunology 32:66-72
20. Zumla A et al (2013) Tuberculosis. N Engl J Med 368:745-755
21. Lowe DM et al (2012) Neutrophils in tuberculosis: friend or foe? Trends in immunology 33:14-25
22. Eum SY et al (2010) Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137:122-128
23. Berry MP et al (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977
24. Ramos-Kichik V et al (2009) Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis 89:29-37
25. Doherty TM (2012) Immunotherapy for TB. Immunotherapy 4:629-647
26. Steinwede K et al (2012) Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice. J Immunol 188:4476-4487
27. Jena P et al (2012) Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages. PLoS One 7:e50345
28. Walters SB et al (2013) Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration. J Immunol 190:669-677
29. Duarte TA et al (2012) Mycobacterium tuberculosis-induced neutrophil ectosomes decrease macrophage activation. Tuberculosis 92:218-225
30. Wong, K.W. and Jacobs, W.R., Jr. (2013) Mycobacterium tuberculosis exploits human interferon-gamma to stimulate macrophage extracellular trap formation and necrosis. The Journal of infectious diseases
31. Feltcher ME et al (2010) Protein export systems of Mycobacterium tuberculosis: novel targets for drug development? Future Microbiol 5:1581-1597
32. Yount NY, Yeaman MR (2013) Peptide antimicrobials: cell wall as a bacterial target. Ann N Y Acad Sci 1277:127-138
33. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75:39-48
34. Gudmundsson GH et al (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. European journal of biochemistry / FEBS 238:325-332
35. Dorschner RA et al (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Investig Dermatol 117:91-97
36. Thennarasu S et al (2010) Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys J 98:248-257
37. Turner J et al (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42:2206-2214
38. Martineau AR et al (2007) Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 117:1988-1994
39. Reinholz M et al (2012) Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol 24:126-135
40. Jung YJ et al (2012) Enhanced resistance to bacterial and fungal pathogens by overexpression of a human cathelicidin antimicrobial peptide (hCAP18/LL-37) in Chinese cabbage. Plant biotechnology reports 6:39-46
41. Nizet V, Gallo RL (2003) Cathelicidins and innate defence against invasive bacterial infection. Scand J Infect Dis 35:670-676
42. Barns, K.J. and Weisshaar, J.C. (2013) Real-time attack of LL-37 on single Bacillus subtilis cells. Biochimica et biophysica acta
43. Nijnik A, Hancock RE (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16:41-47
44. Niyonsaba F et al (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Investig Dermatol 127:594-604
45. Braff MH et al (2007) Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. J Infect Dis 195:1365-1372
46. Choi KY, Mookherjee N (2012) Multiple immune-modulatory functions of cathelicidin host defence peptides. Front Immunol 3:149
47. Lande R et al (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564-569
48. Baumgarth N, Bevins CL (2007) Autoimmune disease: skin deep but complex. Nature 449:551-553
49. Kessenbrock K et al (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nature medicine 15:623-625
50. Hoffmann, M.H., et al. (2012) The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Annals of the rheumatic diseases
51. Gutner M et al (2009) Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect Immun 77:5558-5563
52. Sieprawska-Lupa M et al (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-4679
53. Lauth X et al (2009) M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. Journal of innate immunity 1:202-214
54. Bergsson G et al (2009) LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J Immunol 183:543-551
55. Zheng Y et al (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br J Dermatol 157:1124-1131
56. Tjabringa GS et al (2006) Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. International archives of allergy and immunology 140:103-112
57. Wantha S et al (2013) Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res 112:792-801
58. Zuyderduyn S et al (2006) The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells. The Journal of allergy and clinical immunology 117:1328-1335
59. Engelmann B, Massberg S (2013) Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13:34-45
60. Semeraro F et al (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118:1952-1961
61. Brill A et al (2012) Neutrophil extracellular traps promote deep vein thrombosis in mice. Journal of thrombosis and haemostasis: JTH 10:136-144
62. Das R et al (2007) Histone H2B as a functionally important plasminogen receptor on macrophages. Blood 110:3763-3772
63. Fuchs TA et al (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107:15880-15885
64. Higuchi DA et al (1992) The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood 79:1712-1719
65. Takano S et al (1990) Plasma thrombomodulin in health and diseases. Blood 76:2024-2029
66. Plow EF (1980) The major fibrinolytic proteases of human leukocytes. Biochim Biophys Acta 630:47-56
67. von Bruhl ML et al (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. The Journal of experimental medicine 209:819-835
68. Massberg S et al (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887-896
69. Kambas K et al (2012) The emerging role of neutrophils in thrombosis - the journey of TF through NETs. Front Immunol 3:385
70. Kambas K et al (2012) Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One 7:e45427
71. Xu J et al (2011) Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 187:2626-2631
72. Clark SR et al (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nature medicine 13:463-469
73. Caudrillier, A., et al. (2012) Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest
74. Frick IM et al (2006) The contact system - a novel branch of innate immunity generating antibacterial peptides. EMBO J 25:5569-5578
75. Yeaman MR (2010) Platelets in defence against bacterial pathogens. Cellular and molecular life sciences: CMLS 67:525-544
76. Szaba FM, Smiley ST (2002) Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99:1053-1059
77. Bergmann S, Hammerschmidt S (2007) Fibrinolysis and host response in bacterial infections. Thromb Haemost 98:512-520
78. Sun H et al (2004) Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305:1283-1286
79. Guggenberger C et al (2012) Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog 8:e1002434
80. Cheng AG et al (2010) Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 6:e1001036
81. Cheng OZ, Palaniyar N (2013) NET balancing: a problem in inflammatory lung diseases. Front Immunol 4:1
82. Narasaraju T et al (2011) Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179:199-210
83. Hemmers S et al (2011) PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One 6:e22043
84. Jenne CN et al (2013) Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell host & microbe 13:169-180
85. Wardini AB et al (2010) Characterization of neutrophil extracellular traps in cats naturally infected with feline leukemia virus. J Gen Virol 91:259-264
86. Jarrett O (1996) The relevance of feline retroviruses to the development of vaccines against HIV. AIDS research and human retroviruses 12:385-387
87. Jenne CN, Kubes P (2012) NETs tangle with HIV. Cell host & microbe 12:5-7
88. Saitoh T et al (2012) Neutrophil extracellular traps mediate a host defence response to human immunodeficiency virus-1. Cell host & microbe 12:109-116
89. Gustafsson MG et al (2008) Three-dimensional resolution doubling in wide-field fluorescence microscopy by structured illumination. Biophys J 94:4957-4970
90. da Silva RC et al (2011) Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. Hum Immunol 72:305-311
91. Goletti D et al (1996) Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 157:1271-1278
92. Papayannopoulos V, Zychlinsky A (2009) NETs: a new strategy for using old weapons. Trends in immunology 30:513-521
93. Battle KE et al (2012) The global public health significance of Plasmodium vivax. Adv Parasitol 80:1-111
94. Baker VS et al (2008) Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar J 7:41
95. Waisberg M et al (2011) Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci U S A 108:1122-1127
96. Ben-Zvi I et al (2012) Hydroxychloroquine: from malaria to autoimmunity. Clinical reviews in allergy & immunology 42:145-153
97. Giannoni E et al (2006) Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. American journal of respiratory cell and molecular biology 34:704-710
98. Douda DN et al (2011) Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping. J Immunol 187:1856-1865
99. Thomas GM et al (2012) Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 119:6335-6343
100. Caudrillier A et al (2012) Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 122:2661-2671
101. Narayana Moorthy A et al (2013) In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front Immunol 4:56
102. Papayannopoulos V et al (2011) Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PLoS One 6:e28526
103. Dubois AV et al (2012) Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. American journal of respiratory cell and molecular biology 47:80-86
104. Manzenreiter R et al (2012) Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society 11:84-92
105. Young RL et al (2011) Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One 6:e23637
106. Aagaard-Tillery KM et al (2006) Immunology of normal pregnancy. Semin Fetal Neonatal Med 11:279-295
107. Erlebacher A (2013) Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol 13:23-33
108. Sykes L et al (2012) The Th1:th2 dichotomy of pregnancy and preterm labour. Mediat Inflamm 2012:967629
109. Hahn S et al (2012) Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss. Front Immunol 3:362
110. Gupta A et al (2006) Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA? Ann N Y Acad Sci 1075:118-122
111. Sandu C et al (2013) Hematogenous placental infection in acute respiratory infections. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 54:157-161
112. Proietti E et al (2013) Air pollution during pregnancy and neonatal outcome: a review. Journal of aerosol medicine and pulmonary drug delivery 26:9-23
113. Singh SP et al (2011) Prenatal secondhand cigarette smoke promotes Th2 polarization and impairs goblet cell differentiation and airway mucus formation. J Immunol 187:4542-4552
114. Claude JA et al (2012) Perinatal exposure to environmental tobacco smoke (ETS) enhances susceptibility to viral and secondary bacterial infections. International journal of environmental research and public health 9:3954-3964
115. Kourtis AP et al (2012) Neutrophil count in African mothers and newborns and HIV transmission risk. N Engl J Med 367:2260-2262
116. Cantu J, Tita AT (2013) Management of influenza in pregnancy. Am J Perinatol 30:99-103
117. Takem EN, D'Alessandro U (2013) Malaria in pregnancy. Mediterranean journal of hematology and infectious diseases 5:e2013010
118. Rogerson SJ et al (2007) Malaria in pregnancy: linking immunity and pathogenesis to prevention. AmJTrop Med Hyg 77:14-22
119. Davison BB et al (2005) Alterations in the profile of blood cell types during malaria in previously unexposed primigravid monkeys. J Infect Dis 191:1940-1952
120. Cunnington AJ et al (2012) Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction. J Immunol 189:5336-5346
121. Garcia-Romo, G.S., et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Science translational medicine 3, 73ra20
122. Lande, R., et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Science translational medicine 3, 73ra19
123. Suri R (2005) The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy 19:135-144